These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 3143709)
1. Clinical application of a functional assay for protein C. Triplett DA; Sandquist DS; Musgrave KA Hematol Pathol; 1987; 1(4):239-47. PubMed ID: 3143709 [TBL] [Abstract][Full Text] [Related]
2. Protein C. Esmon CT Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583 [TBL] [Abstract][Full Text] [Related]
3. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment. D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163 [TBL] [Abstract][Full Text] [Related]
4. A protein C pathway (PCP) screening test for the detection of APC resistance and protein C or S deficiencies. Haas FJ; van Sterkenburg-Kamp BM; Scheepers HA Semin Thromb Hemost; 1998; 24(4):355-62. PubMed ID: 9763352 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays. Pabinger I; Kyrle PA; Speiser W; Stoffels U; Jung M; Lechner K Thromb Haemost; 1990 Jun; 63(3):407-12. PubMed ID: 2402742 [TBL] [Abstract][Full Text] [Related]
6. Detecting APC-resistant factor V: a functional method without plasma dilution. Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217 [TBL] [Abstract][Full Text] [Related]
7. The Gla26 residue of protein C is required for the binding of protein C to thrombomodulin and endothelial cell protein C receptor, but not to protein S and factor Va. Nishioka J; Ido M; Hayashi T; Suzuki K Thromb Haemost; 1996 Feb; 75(2):275-82. PubMed ID: 8815576 [TBL] [Abstract][Full Text] [Related]
8. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946 [TBL] [Abstract][Full Text] [Related]
9. A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma. Duchemin J; Pittet JL; Tartary M; Béguin S; Gaussem P; Alhenc-Gelas M; Aiach M Thromb Haemost; 1994 Mar; 71(3):331-8. PubMed ID: 8029798 [TBL] [Abstract][Full Text] [Related]
10. A sensitive and facile assay for the measurement of activated protein C activity levels in vivo. Orthner CL; Kolen B; Drohan WN Thromb Haemost; 1993 May; 69(5):441-7. PubMed ID: 8322267 [TBL] [Abstract][Full Text] [Related]
12. Multicenter comparison of five functional and two immunological assays for protein C. Mannucci PM; Boyer C; Tripodi A; Viganò-D'Angelo S; Wolf M; Valsecchi C; D'Angelo A; Meyer D; Larrieu MJ Thromb Haemost; 1987 Feb; 57(1):44-8. PubMed ID: 3590079 [TBL] [Abstract][Full Text] [Related]
13. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance. Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699 [TBL] [Abstract][Full Text] [Related]
14. Factor V and protein S as cofactors to activated protein C. Dahlbäck B Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093 [TBL] [Abstract][Full Text] [Related]
15. Laboratory tests for protein C deficiency. Khor B; Van Cott EM Am J Hematol; 2010 Jun; 85(6):440-2. PubMed ID: 20309856 [TBL] [Abstract][Full Text] [Related]
16. The dilute phospholipid APTT: a sensitive assay for verification of lupus anticoagulants. Alving BM; Baldwin PE; Richards RL; Jackson BJ Thromb Haemost; 1985 Oct; 54(3):709-12. PubMed ID: 3937268 [TBL] [Abstract][Full Text] [Related]
17. [Rapid determination of protein C activity]. Nicham F; Guichaoua JF; Contant G; Martinoli JL Ann Biol Clin (Paris); 1988; 46(10):805-9. PubMed ID: 3232870 [TBL] [Abstract][Full Text] [Related]
18. [Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin III complex(TAT) and thrombophilia parameters in orally anticoagulated patients with inferior vena cava filters]. Halbmayer WM; Haushofer A; Toth E Wien Med Wochenschr; 1993; 143(5):95-8. PubMed ID: 8511904 [TBL] [Abstract][Full Text] [Related]
19. A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S. van Wijnen M; van 't Veer C; Meijers JC; Bertina RM; Bouma BN Thromb Haemost; 1998 Dec; 80(6):930-5. PubMed ID: 9869163 [TBL] [Abstract][Full Text] [Related]
20. Successful protein C concentrate administration during initiation of oral anticoagulation in adult patients with severe congenital protein C deficiency: report of two cases. Imberti D; Pierfranceschi MG Pathophysiol Haemost Thromb; 2008; 36(2):53-7. PubMed ID: 19127082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]